Hormonal aspects of ménière's disease on the basis of clinical and experimental studies

ORL

Volumn 71, Issue SUPPL. 1, 2010, Pages 1-9

  Takeda, Taizo ^a   Takeda, Setsuko ^a   Kakigi, Akinobu ^a,b   Okada, Teruhiko ^a   Nishioka, Rie ^a   Taguchi, Daizo ^a,c   Nishimura, Masahiko ^a,d   Nakatani, Hiroaki ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c TOTTORI UNIVERSITY   (Japan)

^d OSAKA UNIVERSITY   (Japan)

Author keywords

Aquaporin; Endolymphatic hydrops; M ni re's disease; V2 antagonist; Vasopressin; Vasopressin type 2 receptor

Indexed keywords

AQUAPORIN 2; MESSENGER RNA; VASOPRESSIN V2 RECEPTOR;

AGING; CLINICAL FEATURE; CLINICAL STUDY; COCHLEA; DISEASE COURSE; DISEASE DURATION; DIZZINESS; ENDOLYMPH; ENDOLYMPHATIC SAC; EPITHELIUM; EXPERIMENTAL STUDY; HEARING IMPAIRMENT; HOMEOSTASIS; HUMAN; INNER EAR; MENIERE DISEASE; MORPHOLOGICAL TRAIT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSYCHOSOMATICS; REMISSION; REVIEW; SEX DIFFERENCE; STRIA VASCULARIS; VASOPRESSIN BLOOD LEVEL; VERTIGO;

ANIMALS; AQUAPORIN 2; BENZAZEPINES; DIURETICS; EAR, INNER; ENDOLYMPH; HOMEOSTASIS; HUMANS; LITHIUM; MENIERE DISEASE; RECEPTORS, VASOPRESSIN; VASOPRESSINS; WATER-ELECTROLYTE IMBALANCE;

EID: 77952562478     PISSN: 03011569     EISSN: None     Source Type: Journal    
DOI: 10.1159/000265113     Document Type: Review

References (33)

1. Yamakawa K: Uber die pathologische Veranderung bei einem Meniere-Kranken (in Japanese). J Otolaryngol Jpn 1938; 44: 2310-2312.
2. Hallpike CS, Cairns H: Observation on the pathology of Meniere's syndrome. J Laryngol 1938; 53: 625-655.
3. Watanabe I: Incidence of Meniere's disease, including some other epidemiological data; in Oosterveld W (ed): Meniere's disease: A Comprehensive Appraisal. Chichester, Wiley, 1983, pp 9-23.
4. Takeda T, Kakigi A, Saito H: Antidiuretic hormone and endolymphatic hydrops. Acta Otolaryngol Suppl 1995; 519: 219-222.
5. Takeda T, Kakigi A, Nishioka R, Taguchi D, Nishimura M: Plasma antidiuretic hormone in cases with the early onset of profound unilateral deafness. Auris Nasus Larynx 2008; 35: 493-499.
6. Sawada S, Takeda T, Saito H: Antidiuretic hormone and psychosomatic aspects in Meniere's disease. Acta Otolaryngol Suppl 1997; 528: 109-112.
7. Kitano H, Takeda T, Suzuki M, Kitanishi T, Yazawa Y, Kitajima K, Kimura H, Tooyama I: Vasopressin and oxytocin receptor mRNAs are expressed in the rat inner ear. Neuroreport 1997; 8: 2289-2292.
8. Furuta H, Luo L, Ryan AF, Mori N: Expression of mRNA encoding vasopressin V 1a , vasopressin V 2 , and ANP-B receptors in the rat cochlea. Hear Res 1998; 117: 140-148. (Pubitemid 28157438)
9. De Minteguiaga C, Clerget MS, Tran Ba Huy P, Elalouf JM: 2-Adrenergic but not vasopressin V 2 receptor mRNAs are expressed in the stria vascularis of the rat inner ear. Pflugers Arch 1998; 436: 940-947.
10. Kitano H, Suzuki M, Kitanishi T, Yazawa Y, Kitajima K, Isono T, Takeda T, Kimura H, Tooyama I: Regulation of inner ear fluid in the rat by vasopressin. Neuroreport 1999; 10: 1205-1207.
11. Taguchi D, Takeda T, Kakigi A, Takumida M, Nishioka R, Kitano H: Expressions of aquaporin-2, vasopressin type 2 receptor, transient receptor potential channel vanilloid (TRPV)1, and TRPV4 in the human endolymphatic sac. Laryngoscope 2007; 117: 695-698.
12. Kakigi A, Nishimura M, Takeda T, Taguchi D, Nishioka R: Expression of aquaporin 1, 3, and 4, NKCC1, and NKCC2 in the human endolymphatic sac. Auris Nasus Larynx 2009; 36: 135-139.
13. Nishimura M, Kakigi A, Takeda T, Takeda S, Doi K: Expression of aquaporins, vasopressin type 2 receptor and Na + -K + -Cl - cotransporters in the rat endolymphatic sac. Acta Otolaryngol 2008; Oct 7:1-7 [E-pub ahead of print].
14. Nielsen S, Frokiaer J, Marples D, Kwon TH, Agre P, Knepper MA: Aquaporins in the kidney: from molecules to medicine. Physiol Rev 2002; 82: 205-244.
15. Gallardo P, Cid LP, Vio CP, Sepulveda FV: Aquaporin-2, a regulated water channel, is expressed in apical membranes of rat distal colon epithelium. Am J Physiol 2001; 281: G856-G863.
16. Stankovi KM, Adams JC, Brown D: Immunolocalization of aquaporin CHIP in the guinea pig inner ear. Am J Physiol 1995; 269: C1450-C1456.
17. Takumi Y, Nagelhus EA, Eidet J, Matsubara A, Usami S, Shinkawa H, Nielsen S, Ottersen OP: Select types of supporting cell in the inner ear express aquaporin-4 water channel protein. Eur J Neurosci 1998; 10: 3584-3595.
18. Sawada S, Takeda T, Kitano H, Takeuchi S, Okada T, Ando M: Aquaporin-1 (AQP1) is expressed in the stria vascularis of rat cochlea. Hear Res 2003; 181: 15-19.
19. Minami Y, Shimada S, Miyahara H, Matsunaga T, Tohyama M: Selective expression of mercurial-insensitive water channel (AQP- 4) gene in Hensen and Claudius cells in the rat cochlea. Acta Otolaryngol Suppl 1998; 533: 19-21.
20. Lopez IA, Ishiyama G, Lee M, Baloh RW, Ishiyama A: Immunohistochemical localization of aquaporins in the human inner ear. Cell Tissue Res 2007; 328: 453-460.
21. Kumagami H, Loewenheim H, Beitz E, Wild K, Schwartz H, Yamashita K, Schultz J, Paysan J, Zenner HP: The effect of anti-diuretic hormone on the endolymphatic sac of the inner ear. Pflugers Arch 1998; 436: 970-975.
22. Beitz E, Kumagami H, Krippeit-Drews P, Ruppersberg JP, Schultz JE: Expression pattern of aquaporin water channels in the inner ear of the rat. The molecular basis for a water regulation system in the endolymphatic sac. Hear Res 1999; 132: 76-84.
23. Sawada S, Takeda T, Kitano H, Takeuchi S, Kakigi A, Azuma H: Aquaporin-2 regulation by vasopressin in the rat inner ear. Neuroreport 2002; 13: 1127-1129.
24. Merves M, Bobbitt B, Parker K, Kishore BK, Choo D: Developmental expression of aquaporin 2 in the mouse inner ear. Laryngoscope 2000; 110: 1925-1930.
25. Couloigner V, Berrebi D, Teixeira M, Paris R, Florentin A, Bozorg Grayeli A, Cluzeaud F, Sterkers O, Peuchmaur M, Ferrary E: Aquaporin-2 in the human endolymphatic sac. Acta Otolaryngol 2004; 124: 449-453.
26. Mhatre AN, Jero J, Chiappini I, Bolasco G, Barbara M, Lalwani AK: Aquaporin-2 expression in the mammalian cochlea and investigation of its role in Meniere's disease. Hear Res 2002; 170: 59-69.
27. Fukushima K, Takeda T, Kakigi A, Takeda S, Sawada S, Nishioka R, Azuma H, Taguchi T: Effects of lithium on endolymph homeostasis and experimentally induced endolymphatic hydrops. ORL J Otorhinolaryngol Relat Spec 2005; 67: 282-288.
28. Takeda T, Sawada S, Takeda S, Kitano H, Suzuki M, Kakigi A, Takeuchi S: The effects of V 2 antagonist (OPC-31260) on endolymphatic hydrops. Hear Res 2003; 182: 9-18.
29. Nishimura M, Kakigi A, Takeda T, Okada T, Doi K: Time course changes of vasopressininduced enlargement of the rat intrastrial space and the effects of a vasopressin type 2 antagonist. Acta Otolaryngol 2009; 129: 709-715.
30. Takeda T, Takeda S, Kitano H, Okada T, Kakigi A: Endolymphatic hydrops induced by chronic administration of vasopressin. Hear Res 2000; 140: 1-6.
31. Kitano H, Suzuki M, Kitanishi T, Yazawa Y, Kitajima K, Isono T, Takeda T, Kimura H, Tooyama I: Endolymphatic hydrops by administration of vasopressin in the rat. Acta Histochem Cytochem 2001; 34:229-233.
32. Kitano H, Takeda T, Pulec JL, Saadat D, Uchida K: The relationship between vasopressin and endolymphatic hydrops in the guinea pig. Ear Nose Throat J 1994; 73: 921-925.
33. Schrier RW, Cadnapaphornchai MA, Ohara M: Water retention and aquaporins in heart failure, liver disease and pregnancy. J R Soc Med 2001; 94: 265-269.